InvVax was incorporated in January 2013. Located in sunny Southern California, it maintains a strong affiliation with the UCLA, where its technology was originally developed. InvVax has access to a wide network of leading investigators in diverse disciplines, including molecular virology, immunology, pharmacology, and clinical infectious diseases.
As a fledgling company, we are seeking highly talented applicants for scientific, industrial, and management roles who are interested in building a novel platform for vaccine development, and have a burning desire to make a far-ranging impact on the global human population.
Location: United States, California, Los Angeles
Member count: 1-10
Founded date: 2012
Investors 2
Date | Name | Website |
- | Life Scien... | lifescienc... |
- | Tech Coast... | techcoasta... |
Mentions in press and media 1
Date | Title | Description | Source |
23.10.2018 | InvVax Achieves Preclinical Milestone with Universal Flu Vac... | PASADENA, Calif.–(BUSINESS WIRE)–October 23, 2018– Privately held InvVax, Inc. (Pasadena, CA), in c... | venturebea... |